Reduced medium-term mortality following primary total hip and knee arthroplasty with an enhanced recovery program. A study of 4,500 consecutive procedures
- PMID: 23368747
- PMCID: PMC3584601
- DOI: 10.3109/17453674.2013.771298
Reduced medium-term mortality following primary total hip and knee arthroplasty with an enhanced recovery program. A study of 4,500 consecutive procedures
Abstract
Background and purpose: Our unit started to use routine multimodal techniques to enhance recovery for hip and knee arthroplasty in 2008. We have previously reported earlier discharge, a trend toward a reduction in complications, and a statistically significant reduction in mortality up to 90 days after surgery. In this study, we evaluated the same cohort to determine whether survival benefits were maintained at 2 years.
Patients and methods: We prospectively evaluated 4,500 unselected consecutive total hip and knee replacements. The first 3,000 underwent a traditional protocol (TRAD) and the later 1,500 underwent an enhanced recovery protocol (ER). Mortality data were collected from the Office of National Statistics (UK).
Results: There was a difference in death rate at 2 years (TRAD vs. ER: 3.8% vs. 2.7%; p = 0.05). Survival probability up to 3.7 years post surgery was significantly better in patients who underwent an ER protocol.
Interpretation: This large prospective case series of unselected consecutive patients showed a reduction in mortality rate at 2 years following elective lower-limb hip and knee arthroplasty following the introduction of a multimodal enhanced recovery protocol. This survival benefit supports the routine use of an enhanced recovery program for hip and knee arthroplasty.
Figures


References
-
- Andersen KV, Pfeiffer-Jensen M, Haraldsted V, Soballe K. Reduced hospital stay and narcotic consumption, and improved mobilization with local and intraarticular infiltration after hip arthroplasty: a randomized clinical trial of an intraarticular technique versus epidural infusion in 80 patients. Acta Orthop. 2007;78(2):180–6. - PubMed
-
- Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically? Hematology (Suppl 1) 2005;10:208–14. - PubMed
-
- CancerResearchUK (Accessed 8 Aug 2012): CancerStats UK http://info.cancerresearchuk.org/cancerstats/keyfacts/ http://info.cancerresearchuk.org/cancerstats/keyfacts/
-
- Fleiss JL, Levin B, Paik MC. Hoboken: NJ. J.Wiley; 2003. Statistical methods for rates and proportions.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical